...
首页> 外文期刊>Molecular and Cellular Endocrinology >Overexpression of a dominant-negative type II TGFbeta receptor tagged with green fluorescent protein inhibits the effects of TGFbeta on cell growth and gene expression of mouse adrenal tumor cell line Y-1 and enhances cell tumorigenicity.
【24h】

Overexpression of a dominant-negative type II TGFbeta receptor tagged with green fluorescent protein inhibits the effects of TGFbeta on cell growth and gene expression of mouse adrenal tumor cell line Y-1 and enhances cell tumorigenicity.

机译:用绿色荧光蛋白标记的显性阴性II型TGFbeta受体的过表达抑制TGFbeta对小鼠肾上腺肿瘤细胞系Y-1的细胞生长和基因表达的影响,并增强细胞致瘤性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Transforming growth factor beta (TGFbeta) has been reported to be a potent growth inhibitor of epithelial cells. The purpose of the present work was to study in vitro and in vivo the effects of overexpression of a dominant-negative type II TGFbeta receptor on the proliferation and differentiation of Y-1 cells. Stable transfections were performed with a mutant TbetaRII (TbetaRII-KR) fused with the Enhanced Fluorescent Green Protein (EGFP). The expression of this fusion protein and its overexpression were demonstrated by northern blot and immunoblot with EGFP and TbetaRII probes and antibodies respectively. The membrane localization of this fusion protein was confirmed by confocal microscopy. The functionality of this fusion protein was demonstrated by its blocking effects on TGFbeta action on DNA synthesis and on Y-1 expression of steroidogenic acute regulatory protein (StAR) and 3beta-hydroxysteroid dehydrogenase (3beta-HSD). Moreover, in nude mice the tumorigenicity of cells stably transfected with the fusion protein was higher than that of cells stably transfected with EGFP alone. Taken together, the present results show that TbetaRII-KR/EGFP blocks the effects of TGFbeta1 on Y-1 cells and acts as a potent dominant-negative receptor preventing TGFbeta signaling.
机译:据报道,转化生长因子β(TGFbeta)是上皮细胞的有效生长抑制剂。本工作的目的是在体外和体内研究显性负II型TGFβ受体过表达对Y-1细胞增殖和分化的影响。用融合了增强型荧光绿色蛋白(EGFP)的突变体TbetaRII(TbetaRII-KR)进行稳定的转染。分别通过EGFP和TbetaRII探针和抗体的northern印迹和免疫印迹证明了该融合蛋白的表达及其过表达。通过共聚焦显微镜证实了该融合蛋白的膜定位。该融合蛋白的功能通过其对TGFbeta对DNA合成的作用以及对类固醇生成的急性调节蛋白(StAR)和3beta-羟基类固醇脱氢酶(3beta-HSD)的Y-1表达的阻断作用来证明。此外,在裸鼠中,用融合蛋白稳定转染的细胞的致瘤性高于单独用EGFP稳定转染的细胞的致瘤性。综上所述,目前的结果表明,TbetaRII-KR / EGFP阻断了TGFbeta1对Y-1细胞的作用,并充当了防止TGFbeta信号传导的强效负性受体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号